Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p

Chong Yin1, Ye Tian1, Yang Yu2

  • 1Lab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, Research Center for Special Medicine and Health Systems Engineering, NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.

Pharmacological Research
|October 8, 2020
PubMed

Insights

Two long non-coding RNAs (lncRNAs), AK039312 and AK079370, were found to inhibit bone formation. Their inhibition was reversed in vivo, suggesting potential therapeutic strategies for osteoporosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Bone Biology

Background:

  • Osteoporosis, a health threat linked to aging and menopause, is characterized by reduced osteoblast differentiation.
  • Long non-coding RNAs (lncRNAs) regulate osteoblast differentiation and are potential therapeutic targets for osteoporosis.
  • In vivo rescue effects of lncRNAs for osteoporosis remain under-investigated.

Purpose of the Study:

  • To investigate the role of osteogenic lncRNAs AK039312 and AK079370 in osteoporosis.
  • To elucidate the molecular mechanism by which these lncRNAs affect osteoblast differentiation and bone formation.
  • To evaluate the therapeutic potential of targeting these lncRNAs in a postmenopausal osteoporosis model.

Main Methods:

  • Screening of osteogenic-related lncRNAs.
  • Investigating the inhibitory effects of AK039312 and AK079370 on osteoblast differentiation and bone formation.
  • Analyzing the molecular mechanism involving miR-199b-5p, GSK-3β, and the wnt/β-catenin pathway.
  • Utilizing small interfering RNAs (siRNAs) to target AK039312 and AK079370 in a postmenopausal osteoporosis model.

Main Results:

  • AK039312 and AK079370 were identified as inhibitors of osteoblast differentiation and bone formation.
  • These lncRNAs suppress osteogenic transcription factors by binding and sequestering miR-199b-5p, leading to enhanced GSK-3β and inhibition of the wnt/β-catenin pathway.
  • Administration of siRNAs targeting AK039312 and AK079370 significantly alleviated postmenopausal osteoporosis.
  • Combination therapy with si-AK039312 and si-AK079370 demonstrated greater efficacy than single siRNA treatment.

Conclusions:

  • AK039312 and AK079370 play critical roles in inhibiting osteoblast differentiation and bone formation.
  • Targeting these lncRNAs offers a promising therapeutic strategy for osteoporosis.
  • Combined inhibition of AK039312 and AK079370 provides a more effective approach to treating postmenopausal osteoporosis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.5K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
71.6K